Correlation Between Intel and AN2 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intel and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intel and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intel and AN2 Therapeutics, you can compare the effects of market volatilities on Intel and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intel with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intel and AN2 Therapeutics.

Diversification Opportunities for Intel and AN2 Therapeutics

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Intel and AN2 is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Intel and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Intel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intel are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Intel i.e., Intel and AN2 Therapeutics go up and down completely randomly.

Pair Corralation between Intel and AN2 Therapeutics

Given the investment horizon of 90 days Intel is expected to generate 10.07 times less return on investment than AN2 Therapeutics. But when comparing it to its historical volatility, Intel is 1.63 times less risky than AN2 Therapeutics. It trades about 0.03 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  110.00  in AN2 Therapeutics on August 29, 2024 and sell it today you would earn a total of  29.00  from holding AN2 Therapeutics or generate 26.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Intel  vs.  AN2 Therapeutics

 Performance 
       Timeline  
Intel 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Intel are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Intel exhibited solid returns over the last few months and may actually be approaching a breakup point.
AN2 Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in AN2 Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, AN2 Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Intel and AN2 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Intel and AN2 Therapeutics

The main advantage of trading using opposite Intel and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intel position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.
The idea behind Intel and AN2 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities